Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abaxis Inc (NASDAQ:ABAX)

49.72
Delayed Data
As of 3:59pm ET
 +0.58 / +1.18%
Today’s Change
37.71
Today|||52-Week Range
58.15
-10.70%
Year-to-Date
Abaxis (ABAX) Q1 Earnings Miss Estimates, Sales Up Y/Y
Jul 22 / Zacks.com - Paid Partner Content
Medical Product Earnings on Jul 21: ABAX, ATHN, NURO, SYK
Jul 20 / Zacks.com - Paid Partner Content
3 Stocks Dragging In The Drugs Industry
Jul 22 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close49.14
Today’s open48.80
Day’s range48.80 - 50.29
Volume166,214
Average volume (3 months)185,702
Market cap$1.1B
Dividend yield0.97%
Data as of 3:59pm ET, 07/28/2016

Growth & Valuation

Earnings growth (last year)+57.46%
Earnings growth (this year)-1.45%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+8.05%
P/E ratio36.6
Price/Sales4.74
Price/Book4.66

Competitors

 Today’s
change
Today’s
% change
ELGXEndologix Inc+0.07+0.49%
INGNInogen Inc+0.87+1.68%
MMSIMerit Medical System...+0.27+1.16%
NVCRNovocure Ltd-3.35-29.28%
Data as of 3:59pm ET, 07/28/2016

Financials

Next reporting dateOctober 18, 2016
EPS forecast (this quarter)$0.36
Annual revenue (last year)$218.9M
Annual profit (last year)$31.1M
Net profit margin14.20%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Clinton H. Severson
President &
Chief Operating Officer
Donald Peter Wood
Corporate headquarters
Union City, California

Forecasts

Partner Offers

Search for Jobs